Dacarbazine Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with dacarbazine
S
- saccharomyces boulardii lyo
- Saccharomyces Boulardii+MOS (saccharomyces boulardii lyo)
- samarium sm 153 lexidronam
- Sanofi Pasteur COVID-19 Vaccine, Adjuvanted For Booster Immunization PF (sars-cov-2 pres dtm (booster only) vaccine, recombinant)
- Sarclisa (isatuximab)
- sargramostim
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine
- sars-cov-2 (covid-19) mrna (tozinameran 5y-11y) bivalent booster vaccine
- sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent booster vaccine
- sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent vaccine
- sars-cov-2 (covid-19) mrna-1273 (6m-5y bivalent booster) vaccine
- sars-cov-2 (covid-19) mrna-1273 (bivalent booster) vaccine
- sars-cov-2 (covid-19) mrna-1273 bivalent vaccine
- sars-cov-2 (covid-19) mrna-1273 vaccine
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 311)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 312)
- sars-cov-2 (covid-19) mrna(tozinameran12y+) bivalent vaccine
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 (covid-19)mrna-1273(6y+ bivalent booster) vaccine
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- sars-cov-2(covid-19)mrna(tozinameran 5y-11y)bivalent vaccine
- Sclavo Test-PPD (tuberculin purified protein derivative)
- Selarsdi (ustekinumab)
- Shingrix (zoster vaccine, recombinant)
- Siklos (hydroxyurea)
- Simlandi (adalimumab)
- Simponi (golimumab)
- Simponi Aria (golimumab)
- siponimod
- sipuleucel-T
- Sirturo (bedaquiline)
- skin test antigens, multiple
- smallpox and monkeypox vaccine
- smallpox vaccine
- sodium phosphate p32
- Sotyktu (deucravacitinib)
- sparfloxacin
- Spherulin (coccidioidin skin test)
- Spikevax (2023-2024) PF (cvx 312) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 312))
- Spikevax (sars-cov-2 (covid-19) mrna-1273 vaccine)
- Spikevax PF (sars-cov-2 (covid-19) mrna-1273 vaccine)
- Stamaril (yellow fever vaccine)
- staphage lysate (spl)
- Stelara (ustekinumab)
- Stimufend (pegfilgrastim)
- streptococcus salivarius
- streptozocin
- strontium-89 chloride
- Superdophilus (lactobacillus acidophilus)
- Sustiva (efavirenz)
- Symfi (efavirenz / lamivudine / tenofovir disoproxil)
- Symfi Lo (efavirenz / lamivudine / tenofovir disoproxil)
- Synribo (omacetaxine)
More about dacarbazine
- dacarbazine consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.